Certain transactions - Schedule of Asset Acquisition (Details) - Emalex Biosciences $ in Millions |
Jun. 10, 2026
USD ($)
|
|---|---|
| Certain Transactions [Line Items] | |
| Cash consideration for outstanding shares, net of working capital adjustments | $ 696 |
| Transaction costs | 8 |
| Total consideration allocated | 704 |
| Other current assets | 2 |
| Deferred income taxes | 134 |
| Valuation allowance | (134) |
| Accrued expenses | (18) |
| Other liabilities | (4) |
| Total identifiable assets and liabilities acquired | (20) |
| Acquired IPR&D | $ 724 |
| X | ||||||||||
- Definition Asset Acquisition, Accrued Expenses No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Acquired In Process Research and Development Assets No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition Consideration Transferred Cash No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Deferred Income Taxes No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Identifiable Assets And Liabilities Acquired Net No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Other Current Assets No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Other Liabilities No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Valuation Allowance No definition available.
|
| X | ||||||||||
- Definition Certain Transactions [Line Items] No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of transaction cost incurred as part of consideration transferred in asset acquisition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|